Clinical Comparison of 3 Different Double Eyelid Surgeries-An Improved Double Eyelid Surgical Technique: Minimally Invasive 3-Point Subcutaneous Tunnel Eyelid Surgery.

医学 眼睑 外科 整形外科 眼睑成形术 睑裂
作者
E. Yang,Zhang Hengshu
出处
期刊:Annals of Plastic Surgery [Lippincott Williams & Wilkins]
标识
DOI:10.1097/sap.0000000000002991
摘要

OBJECTIVE Double blepharoplasty or double eyelid surgery is a common plastic surgery in Asians. Our study aimed to evaluate the advantages and disadvantages of the minimally invasive 3-point subcutaneous tunnel double eyelid surgical technique relative to other commonly used approaches. METHOD The study compared 852 single eyelid patients electing 1 of 3 double eyelid surgical options; minimally invasive 3-point subcutaneous tunnel, minimally invasive 3-point embedding, or incision double eyelid surgery. Evaluation criteria included postoperative swelling, hyperemia, pain, scarring, single eyelid recurrence, and patient satisfaction after 2 years. RESULTS All surgical methods effectively achieved double eyelids. Directly after the procedure, the minimally invasive 3-point embedding method produced the mildest degree of swelling and congestion, followed by the 3-point subcutaneous tunnel method and then the incision method (F = 523.908, P = 0.000). The incision method also resulted in more serious postoperative pain, whereas the other 2 methods were equivalent (F = 83.117, P = 0.000). Patients in the incision group had the most severe scars compared with the other 2 groups with milder scarring (F = 882.102, P = 0.000). The minimally invasive 3-point embedding method group had the highest single eyelid recurrence rate (5.88%), whereas the recurrence rates for the other 2 methods were less than 1%. Patients satisfaction after 2 years was highest in the minimally invasive 3-point subcutaneous tunneling method, followed by the 3-point embedding method and lastly the incision method (F = 25.931, P = 0.00). CONCLUSIONS Minimally invasive 3-point subcutaneous tunnel double eyelid surgery has advantages over other techniques, and its clinical application is worth promoting for suitable patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
倪l完成签到,获得积分10
1秒前
liu发布了新的文献求助10
3秒前
和和和完成签到,获得积分10
5秒前
6秒前
充电宝应助科研通管家采纳,获得10
8秒前
香蕉觅云应助科研通管家采纳,获得10
8秒前
NICAI应助科研通管家采纳,获得10
8秒前
科研通AI5应助科研通管家采纳,获得10
8秒前
科研通AI5应助科研通管家采纳,获得10
8秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
嘿嘿应助科研通管家采纳,获得10
9秒前
CodeCraft应助科研通管家采纳,获得10
9秒前
CodeCraft应助科研通管家采纳,获得10
9秒前
慕青应助科研通管家采纳,获得10
9秒前
科研通AI5应助科研通管家采纳,获得10
9秒前
今后应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
9秒前
9秒前
哈哈发布了新的文献求助10
10秒前
JamesPei应助研友_Ze2vV8采纳,获得10
10秒前
英姑应助怕黑傲珊采纳,获得10
11秒前
17秒前
oi发布了新的文献求助10
17秒前
共享精神应助研友_Ze2vV8采纳,获得10
21秒前
微毒麻醉完成签到,获得积分10
21秒前
果果完成签到,获得积分10
23秒前
23秒前
是真灵还是机灵完成签到 ,获得积分10
24秒前
Tabby完成签到,获得积分10
25秒前
26秒前
27秒前
54完成签到,获得积分10
27秒前
song完成签到 ,获得积分10
28秒前
29秒前
光崽是谁发布了新的文献求助10
31秒前
Eva完成签到,获得积分10
31秒前
淞33完成签到 ,获得积分10
31秒前
朴素的尔云完成签到,获得积分10
32秒前
高分求助中
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Animal Physiology 2000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Am Rande der Geschichte : mein Leben in China / Ruth Weiss 1500
CENTRAL BOOKS: A BRIEF HISTORY 1939 TO 1999 by Dave Cope 1000
Machine Learning Methods in Geoscience 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3741439
求助须知:如何正确求助?哪些是违规求助? 3284100
关于积分的说明 10038416
捐赠科研通 3000937
什么是DOI,文献DOI怎么找? 1646889
邀请新用户注册赠送积分活动 783919
科研通“疑难数据库(出版商)”最低求助积分说明 750478